Ren De

Rendu Bio is a leading Chinese biotechnology company specializing in molecular diagnostics, particularly focusing on RNA-based detection technologies. The company has developed a proprietary platform known as Simultaneous Amplification and Testing (SAT), which allows for the rapid and sensitive detection of pathogens by targeting ribosomal RNA. Their commercial portfolio includes a wide range of diagnostic kits for sexually transmitted infections, respiratory diseases, and reproductive health. Rendu Bio is recognized for its innovation in automated molecular testing systems that integrate sample processing and detection, providing efficient solutions for clinical laboratories and hospitals.